Figure 1. RFS and OS for lymphoma... | American Society of Hematology

Figure 1.

Figure 1. RFS and OS for lymphoma patients undergoing ASCT with Bu/Cy/VP treated with q6 vs. q24 hour weight-based Bu dosing.

RFS and OS for lymphoma patients undergoing ASCT with Bu/Cy/VP treated with q6 vs. q24 hour weight-based Bu dosing.

This Feature Is Available To Subscribers Only

Sign In or Create an Account